Phase I study of sorafenib in combination with docetaxel and prednisone in chemo-naïve patients with metastatic castration-resistant prostate cancer

Feby Mardjuadi, Jacques Medioni, Joseph Kerger, Lionel D'Hondt, Jean Luc Canon, Lionel Duck, Flora Musuamba Tshinanu, Stephane Oudard, Marylene Clausse, Anne Moxhon, Jean Pascal Machiels

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Phase I study of sorafenib in combination with docetaxel and prednisone in chemo-naïve patients with metastatic castration-resistant prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds